Share on StockTwits

Victrex (LON:VCT) was downgraded by research analysts at Numis Securities Ltd to a “hold” rating in a report released on Tuesday, Analyst Ratings.Net reports. They currently have a GBX 1,831 ($30.09) target price on the stock. Numis Securities Ltd’s price target would suggest a potential downside of 5.96% from the stock’s previous close.

Victrex (LON:VCT) traded up 10.37% during mid-day trading on Tuesday, hitting GBX 1946.9999. The stock had a trading volume of 330,196 shares. Victrex has a one year low of GBX 1459.00 and a one year high of GBX 1959.22. The stock’s 50-day moving average is GBX 1807.56 and its 200-day moving average is GBX 1650.81. The company’s market cap is £1.644 billion.

Several other analysts have also recently commented on the stock. Analysts at Jefferies Group reiterated a “hold” rating on shares of Victrex in a research note to investors on Tuesday. They now have a GBX 1,760 ($28.92) price target on the stock. Separately, analysts at Barclays raised their price target on shares of Victrex from GBX 2,000 ($32.87) to GBX 2,160 ($35.50) in a research note to investors on Thursday, January 23rd. They now have an “overweight” rating on the stock. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of GBX 1,574.29 ($25.87).

Victrex plc is engaged in the manufacturing and selling of high performance polymers. The Company’s business is organized as two business units: Victrex Polymer Solutions (LON:VCT) and Invibio Biomaterial Solutions (Invibio).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.